News for 'immunisation'

NTAGI moots booster dose for foreign travellers before 9-month gap

NTAGI moots booster dose for foreign travellers before 9-month gap

Rediff.com5 May 2022

The NTAGI has recommended that those who need to travel overseas can take the precaution dose of Covid vaccine as required by the country they are travelling to, before the stipulated nine-month waiting period, sources told PTI.

COVID-19: 'Dummy vaccination' begins in 4 states

COVID-19: 'Dummy vaccination' begins in 4 states

Rediff.com28 Dec 2020

As the country eagerly awaits an expected coronavirus vaccination drive in January, at least 125 intended beneficiaries each in four states who had registered on the Co-WIN App were on Monday sent SMSes informing them about the time and place of their 'COVID-19 vaccination' under a mock-drill to administer the shots at designated centres.

Vaccine for children over 12 yrs likely by Aug: NTAGI chief

Vaccine for children over 12 yrs likely by Aug: NTAGI chief

Rediff.com27 Jun 2021

Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

Zydus Cadila proposes Rs 1,900 for 3 jabs of DNA-based vaccine

Rediff.com3 Oct 2021

With talks underway between the central government and Zydus Cadila over the pricing of the COVID-19 vaccine ZyCov-D, the pharma company is learnt to have proposed a price of Rs 1,900 for its three-dose jab that can be given to those above 12 years of age.

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech completes phase-III trials for nasal Covid vaccine

Rediff.com15 Aug 2022

The company said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster dose, for subjects who have been double vaccinated with the two commonly administered Covid vaccines in India.

Both vaccines safe, only 0.18% adverse events: Govt

Both vaccines safe, only 0.18% adverse events: Govt

Rediff.com20 Jan 2021

Addressing a press conference, NITI Aayog member (Health) V K Paul said concerns about adverse effects and serious problems post immunisation, as of now, seem to be unfounded, negligible and insignificant, and stressed that both the vaccines -- Covishield and Covaxin -- are safe.

Is A Vaccine Booster Needed?

Is A Vaccine Booster Needed?

Rediff.com20 Dec 2021

'There is no emergency of a third wave that we are rushing for booster doses.'

'Rural spread poses significant danger'

'Rural spread poses significant danger'

Rediff.com18 May 2021

'There is a deep stigma or taboo attached to COVID-19 in rural areas.' 'People don't want to test because they fear social exclusion.' 'Even those who test positive may not reveal and not follow the quarantine protocol.'

Serum Institute chief Adar Poonawalla takes Covishield jab

Serum Institute chief Adar Poonawalla takes Covishield jab

Rediff.com16 Jan 2021

Poonawalla wished the country and Prime Minister Narendra Modi success for the vaccination programme.

India likely to reduce Covid booster gap to 6 months, decision on Friday

India likely to reduce Covid booster gap to 6 months, decision on Friday

Rediff.com27 Apr 2022

The government is likely to soon reduce the gap between the second dose of Covid-19 vaccine and the precaution dose from the current nine months to six months, official sources said on Wednesday.

Masks are a must even after vaccine!

Masks are a must even after vaccine!

Rediff.com16 Jan 2021

'Until the case load starts dropping, we will have to keep up the current level of prevention activities.'

Anganwadis, schools to be used as COVID-19 vaccination sites

Anganwadis, schools to be used as COVID-19 vaccination sites

Rediff.com6 Nov 2020

Each person in the immunisation list would be linked with their Aadhaar cards to avoid duplication and to track beneficiaries.

Booster dose better at protecting Omicron patients above 65: Study

Booster dose better at protecting Omicron patients above 65: Study

Rediff.com8 Jan 2022

The UK Health Security Agency (UKHSA) analysis showed that around three months after the third jab, protection against hospitalisation among those aged 65 and over remains at about 90 per cent.

Experts feel COVID-19 has reached endemic phase

Experts feel COVID-19 has reached endemic phase

Rediff.com30 Oct 2022

According to some experts, there is not much difference in the number of seasonal flu cases and that of COVID-19, even though they stressed that surveillance for newer variants should continue in the off chance of a new lineage of coronavirus catching the country off guard.

DCGI gives nod for study on mixing Covaxin, Covishield

DCGI gives nod for study on mixing Covaxin, Covishield

Rediff.com11 Aug 2021

An expert panel of the Central Drugs Standard Control Organisation on July 29 had recommended granting permission for conducting the study.

COVID-19 vaccines not mandatory, Centre tells SC

COVID-19 vaccines not mandatory, Centre tells SC

Rediff.com22 Mar 2022

'he Centre has not issued any mandate, the stand of centre is that it should be 100 per cent but it is not a mandate'

Covishield, Covaxin get regular market approval

Covishield, Covaxin get regular market approval

Rediff.com27 Jan 2022

Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adverse event following immunisation will continue to be monitored.

NTAGI mulls 'additional' Covid jab for immunocompromised

NTAGI mulls 'additional' Covid jab for immunocompromised

Rediff.com5 Dec 2021

According to officials, an additional dose of vaccine is different from a booster dose.

34 new drugs added to 'essential medicines' list, 26 dropped

34 new drugs added to 'essential medicines' list, 26 dropped

Rediff.com14 Sep 2022

As many as 34 new drugs were added to and 26 dropped from an updated list of essential medicines on Tuesday, with the government saying this will reduce "patients' out-of-pocket expenditure". The National List of Essential Medicines (NLEM 2022) has 384 drugs, up from 376 in 2015. "Drafting this list is a lengthy process, and around 350 experts from across India have held over 140 consultation meetings to draft the NLEM 2022," Union Health Minister Mansukh Mandaviya said.

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

Govt panel recommends reducing Covid booster dose gap to 6 months

Govt panel recommends reducing Covid booster dose gap to 6 months

Rediff.com16 Jun 2022

The Standing Technical Sub-Committee (STSC) of the National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended reducing the gap between the second and precaution doses of COVID-19 vaccines from the current nine to six months, official sources said.

COVID-19: You may need a 'vaccine passport' to fly around the world

COVID-19: You may need a 'vaccine passport' to fly around the world

Rediff.com15 Feb 2021

Several companies and technology heavyweights including Microsoft, Oracle and Salesforce are working to create a digital vaccination passport or health passport app in the hope that governments and airlines will require travellers to upload details of their Covid-19 tests and immunisation. The vaccine passport will effectively create digital credentials that could be the key to attending crowded events or even visiting countries.

Vaccination: Delhi guard, Kolkata nurse admitted to hospital

Vaccination: Delhi guard, Kolkata nurse admitted to hospital

Rediff.com16 Jan 2021

One 'severe' and 51 'minor' cases of AEFI (adverse events following immunisation) were reported among healthcare workers who were administered the coronavirus vaccine in Delhi on the first day of the COVID-19 vaccination drive on Saturday, official figures showed.

COVID-19 vaccine: The Need for Caution

COVID-19 vaccine: The Need for Caution

Rediff.com20 Jul 2020

History shows us that even effective vaccines could have unknown side effects that could develop over time, warns former Cabinet Secetary K M Chandrasekhar.

India confirms first death following COVID-19 vaccination

India confirms first death following COVID-19 vaccination

Rediff.com15 Jun 2021

According to a report by the National AEFI Committee, a 68-year-old man died due to anaphylaxis (severe allergic reaction) after being vaccinated on March 8, 2021.

India may get first Covid-19 vaccine by February

India may get first Covid-19 vaccine by February

Rediff.com30 Nov 2020

The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.

Don't worry over gap between Covishield jabs: Govt

Don't worry over gap between Covishield jabs: Govt

Rediff.com11 Jun 2021

The government on Friday said there is no need to panic on the need for an immediate change in the dosage interval of Covishield vaccine, underlining that reducing the time gap requires proper scientific study in the Indian scenario.

Centre advises use of mask in crowded areas amid fresh Covid scare

Centre advises use of mask in crowded areas amid fresh Covid scare

Rediff.com21 Dec 2022

He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.

Who will get the COVID-19 vaccine first?

Who will get the COVID-19 vaccine first?

Rediff.com25 Nov 2020

'You will not have a vaccine for everyone initially.'

Dom's Take: Vaccine Politics

Dom's Take: Vaccine Politics

Rediff.com23 Oct 2020

is puzzled by the politics of the COVID-19 vaccine. Will only Indians in states going to the polls get a vaccine shot? What happens to Indians in non-election bound states? When will they be protected from the pandemic?

Precautionary dose will be same as first 2 shots: Govt

Precautionary dose will be same as first 2 shots: Govt

Rediff.com6 Jan 2022

Under the National COVID-19 Vaccination Programme, more than 148 crore vaccine doses have been successfully administered.

Kolkata nurse fainted after taking Covid vaccine, stable

Kolkata nurse fainted after taking Covid vaccine, stable

Rediff.com17 Jan 2021

The nurse was on Saturday admitted to hospital as she complained of uneasiness and fainted shortly after taking the shot, during the nationwide vaccination programme.

When I took the COVID-19 vaccine

When I took the COVID-19 vaccine

Rediff.com25 Jan 2021

'I want to send a positive message to people that they should not fear the Covid vaccine.'

'Around 100 million doses will definitely be wasted'

'Around 100 million doses will definitely be wasted'

Rediff.com13 Aug 2022

'We are trying to salvage 50-100 million doses of Covishield with the latest drive on booster doses.'

2 Punjab districts chosen for dry run of Covid vaccine

2 Punjab districts chosen for dry run of Covid vaccine

Rediff.com25 Dec 2020

'The districts of Ludhiana and Shaheed Bhagat Singh Nagar have been selected for the dry run,' Punjab Health Minister Balbir Singh Sidhu said in an official statement.

Lockdown not being considered yet in Delhi: Kejriwal

Lockdown not being considered yet in Delhi: Kejriwal

Rediff.com2 Apr 2021

The chief minister, however, added, "It's a matter of concern since the COVID-19 cases are rising exponentially. But there is no need to panic. The government is monitoring the situation and taking all necessary steps."

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

Omicron: 25 cases in India so far, mainly mild symptoms: Govt

Omicron: 25 cases in India so far, mainly mild symptoms: Govt

Rediff.com10 Dec 2021

The government on Friday said 25 cases of the Omicron variant of the coronavirus have been detected in India so far and that mostly mild symptoms have been noted in all the cases.

BJP leader in UP 'given' 5 vax jabs, 6th 'scheduled'; probe ordered

BJP leader in UP 'given' 5 vax jabs, 6th 'scheduled'; probe ordered

Rediff.com20 Sep 2021

The vaccination certificate of a Bharatiya Janata Party booth level leader in Meerut wrongly shows he has been given five doses of the coronavirus vaccine and is scheduled for the sixth, with officials saying it appears to be a case of 'mischief' and conspiracy.

90-year-old Maggie world's first to get anti-COVID jab

90-year-old Maggie world's first to get anti-COVID jab

Rediff.com8 Dec 2020

Maggie is among the first set of people contacted in advance by the NHS for the jab based on a pre-determined health risk criteria and will include 87-year-old British Indian grandfather of nine Hari Shukla, who will get his first dose at a hospital in Newcastle.